EPCAM and neoplasm: To selectively separate these rare cells from blood, many “label-based” methods have been developed to isolate cells based on surface antigen-based capture (e.g. epithelial cell adhesion molecule, EpCAM)7, 8, 9, but these approaches are limited by heterogeneous inter/intra-tumor protein expression10, 11.